Managing rheumatic and musculoskeletal diseases - past, present and future (Q38670973)

5 September 2017

1 reference

title

Managing rheumatic and musculoskeletal diseases - past, present and future (English)

1 reference

5 September 2017

author

Gerd-Rüdiger Burmester

series ordinal

1

object named as

Gerd R Burmester

1 reference

5 September 2017

3

Maurizio Cutolo

1 reference

5 September 2017

Johannes W J Bijlsma

2

1 reference

5 September 2017

Iain B McInnes

series ordinal

4

1 reference

5 September 2017

language of work or name

English

0 references

publication date

15 June 2017

1 reference

Nature Reviews Rheumatology

5 September 2017

published in

1 reference

5 September 2017

volume

13

1 reference

5 September 2017

issue

7

1 reference

5 September 2017

page(s)

443-448

1 reference

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Janus kinase inhibitors for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

The cost-effectiveness of total joint arthroplasty: a systematic review of published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Knee Joint Distraction Compared to Total Knee Arthroplasty for Treatment of End Stage Osteoarthritis: Simulating Long-Term Outcomes and Cost-Effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Therapeutic application of mesenchymal stem cells in osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Patient-centred care in established rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Rheumatoid factor revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

The ramifications of HLA-B27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

History of neuroimaging: the legacy of William Oldendorf

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Computed tomography: revolutionizing the practice of medicine for 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Grey scale ultrasonography and arthrography in evaluation of popliteal cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Guidelines for musculoskeletal ultrasound in rheumatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Assessing microvascular changes in systemic sclerosis diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Digital medicine: empowering both patients and clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Efficacy of low-dose methotrexate in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

[Absorption of L. E. factor by isolated cell nuclei]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Antinuclear antibody- and extractable nuclear antigen-related diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

The diagnosis of congenital hip-joint dislocation by the ultrasonic Combound treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2017.95

7 January 2021

inferred from DOI database lookup

OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 3: an international multicenter reliability study using the RA-MRI Score

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28615732

12 December 2020

inferred from PubMed ID database lookup

Presentation of two bone marrow elements; the tart cell and the L.E. cell.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28615732

12 December 2020

inferred from PubMed ID database lookup

Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28615732

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRRHEUM.2017.95

1 reference

Dimensions Publication ID

5 September 2017

1086036190

0 references

1 reference